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IN a previous experiment (Cohen and Cohen, 1953) the LD50 for the treatment
of the C3H adenocarcinoma in situ was found to be 5700 (+ 140) r. It was
considered that this quantity was not necessarily a fixed property of the tumour,
but was probably dependent upon the state of the host. Both spontaneous
and radiation-induced regression of tumours are known to be associated with
stromal andlymphoidreactions or similarmanifestations ofaresistance mechanism
in the host (Murphy, 1926). It has been shown that total body radiation can
affect the host to such an extent that spontaneous regression of a homoplast
can be reversed (Cohen and Cohen, 1951) and even genetic resistance to a hetero-
logous implant can be overcome (Clemmesen, 1938). It seemed likely, therefore,
that total body irradiation would also tend to prevent radiation-induced regres-
sion of tumours, and might consequently modify the curative dose for treatment
in situ. Accordingly, in the following experiment, the quantitative effect of
total body radiation of the host on the radiocurability of the C3H mammary
tumour is demonstrated.
MATERIALS AND METHODS.
Animals.
The mice used in this investigation are a registered subline, designated
C3H/Cg, originating from a high mammary tumour strain C3H/Jax, which has
been maintained in this laboratory since 1951. The technique of homoiotrans-
plantation and irradiation of tumour homoplasts in situ is identical with that
reported in a previous paper (Cohen and Cohen, 1953).
Radiation factors.
The total body dose was given with 240 kV., 1 mm. Cu + 1 mm. Al filter,
HVL 1-5 mm. Cu, FSD 50 cm.; the mice being treated en masse in a shallow
cardboard box measuring 20 x 20 x 3 cm., at a surface dose rate of 50 r/min.
At this quality ofradiation, the dosage distribution throughout the body of each
mouse is practically homogeneous.
Experimental design.
In a recent paper (Kaplan and Brown, 1952) it was shown that a maximal
depression of host resistance to tumour induction with a minimal mortality of
mice could be obtained by total body radiation delivered in 4 fractions at four-RADIOBIOLOGY OF THE C3H MOUSE MAMMARY CARCINOMA
day intervals. Since our experiment involved the additional factor ofirradiation
of a tumour in situ, it was considered that the treatment of an average volume
of 500 mm.3 of tumour with 7500-9000 r would constitute one of the total body
fractions (body dose equivalent to 2-5 per cent of tumour dose). Twenty-four
tumour-bearing mice were divided into four equal groups as follows:
(1) The mice were subjected to 3 fractions, each of 100 r, total body irradiation
at four-day intervals, and the tumours then treated with 7500 r four days after
the third fraction.
(2) The tumours were treated with 7500 r, and the animals then subjected to
3 fractions of 100 r total body irradiation at four-day intervals.
(3) The same as (1), but the tumours were treated with 9000 r.
(4) The same as (2), but the tumours were treated with 9000 r.
The lower tumour dosage level (7500 r) was chosen in order to exceed the
LD50, as determined in the previously reported control series (5700 r), by a factor
approaching 3 times the standard deviation, so that the probability of failing
to cure a control mouse at this dose is less than 1 per cent.
The proportion of cures at the two dose levels was determined, and the LD50
and individual variance estimated graphically on the log-probit diagram (Fig. 1)
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FIG. 1.-Response of tumour at two dosage levels in mice given whole body irradiation (c)
compared with a previously deternined control series (A). The increased median effective
dose, increased variance, and probable departure from linearity in the case of totally
irradiated animals is illustrated.
assuming, for the purpose of analysis, that the plot is linear. Taking the three
groups of 13 mice treated in situ in our previous paper as controls, the magnitude
and significance ofeffects that can be attributed to the body dose can be estimated
on the analogy of a five-point assay.
RESULTS.
In Table I the results of treatment of the C3H mammary adenocarcinoma at
two dose levels, in conjunction with total body irradiation of the host, is shown.
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TABLE I.-Treatment of the C3H Adenocarcinoma in situ in Conjunction
with Total Body Irradiation of the Host.
Tumour Body dose Number Number Cures,
dose (r). delivered: of mice. cured.
C Prior to treatment 1
of tumour. . 6 . 3
7500 . .. 42
Following treatment
of tumour reatm6 n 2
Prior to treatment
of tumour.. 6 . 5
9000 75
|Following treatment 7
of tumour . e n 6 4
Although the probability of cure at the dosage given is normally over 99 per
cent, 10 out of the 24 experimental animals treated showed a transient regression
of their tumours, which soon resumed vigorous growth with early ulceration
leading to death from haemorrhage and infection. There were no gross metas-
tases to other sites. Ofseven female mice used in the experiment, four developed
multiple autogenous tumours within two months of irradiation, though, in two
of these, the homoplast was cured.
The proportion of cures at the two-dose levels are plotted in Fig. 1 (Line C),
together with the probit line derived in the previously reported control series
(Line A). The linear interpolation shows that the LD50 in the case of the totally
irradiated animals is 7900 (± 480*) r, which is larger than that of the control
series by a factor of 138 (i 0.09*). This difference is significanat at p = *0001.
The slope of the line indicates a coefficient of variation of 23 per cent, which
is much larger than that in the control series, and is probably due to interaction
between two variables, in that the body dose necessarily increases with increasing
tumour dose. The dotted lines in Fig. 1 show the expected trend, extrapolated
to higher and lower doses, but it was not considered practically feasible or suffi-
ciently important to sacrifice large numbers of mice to define this trend in detail.
With larger doses the deleterious effects are intensified, the host resistance is
still further depressed, and the inevitably high immediate mortality largely
invalidates the results. The systemic action of the radiation together with local
destruction of the stroma and possibly some radionecrosis, all tend to diminish
the radiocurability of tumours treated with excessively large doses.
These experimental results indicate that the curative dose in irradiation of
tumours is a relative quantity dependent upon the resistance of the host. When
clinical radiotherapy necessitates a high body dose, often unavoidable in treat-
ment of deep-seated tumours with conventional techniques, a significantly lower
proportion ofcures might be expected even ifa tumour dose, known to be curative
in an accessible site, has been delivered.
SUMMARY.
The LD50 for irradiation of the C3H mammary adenocarcinoma in situ was
found to be 7900 (+ 480) r when the tumour-bearing hosts were given whole
body radiation totalling 300 r in 3 fractions. This dose is significantly larger
* Standard errors of median and of ratio of medians.
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than the LD50 of 5700 r reported in a control series without total body irradiation,
indicating that a large body dose tends to prevent the radiation-induced regres-
sion of tumours. It appears, therefore, that the curative dose is a relative
quantity, and that host-resistance plays a vital role in the curability of cancer.
We are deeply indebted to Dr. J. F. Murray for generously providing all the
necessary facilities at the South African Institute for Medical Research, where
this C3H/Cg tumour colony is maintained.
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